Putnam Investments’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $516K | Buy |
12,978
+3,257
| +34% | +$129K | ﹤0.01% | 929 |
|
|
2023
Q3 | $310K | Buy |
9,721
+1,843
| +23% | +$58.8K | ﹤0.01% | 1065 |
|
|
2023
Q2 | $317K | Sell |
7,878
-238
| -3% | -$9.56K | ﹤0.01% | 1078 |
|
|
2023
Q1 | $347K | Sell |
8,116
-332
| -4% | -$14.2K | ﹤0.01% | 1051 |
|
|
2022
Q4 | $406K | Buy |
+8,448
| New | +$406K | ﹤0.01% | 984 |
|